In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing...

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study...

Research raises possibility that tirzepatide could become first pharmaceutical treatment for the sleeping disorder

A new drug trial is working to cure obstructive sleep apnoea in Australians.

TUESDAY, June 24, 2024 -- Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women...

FRIDAY, June 21, 2024 -- A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.The worldwide clinical trial...

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am...